| LBEPB18 | Anti-PD-L1 antibody ASC22 in combination with chidamide potentiates HIV latency reversal and immune function from ART-suppressed individuals: a single center, single-arm, phase 2 study | E-poster | Other strategies and therapies |
| LBEPB19 | Factors associated with COVID-19 vaccination uptake amongst PLHIV in southern Nigeria | E-poster | SARS-CoV-2, COVID-19 and HIV |
| LBEPB20 | T-cell responses induced by HTI vaccines and vesatolimod correlate with improved control of HIV rebound | E-poster | Other strategies and therapies |
| LBEPC21 | HIV transmission clusters in Zambia are smaller than in Europe: evidence from the HPTN-071 (PopART) study, BEEHIVE study, and individual-based models | E-poster | Surveillance: Measuring the HIV epidemic |
| LBEPC22 | Preliminary results of the bio behavioral survey among prisoners in Mozambique | E-poster | Surveillance: Measuring the HIV epidemic |
| LBEPC23 | Relative risk of death during pre-Delta, Delta and Omicron variants waves among children and adults hospitalized with COVID-19 in Africa | E-poster | Epidemiology of COVID-19 |
| LBEPC24 | Growth and neurodevelopmental outcomes of 18-month-old children with exposure to maternal HIV and placental insufficiency in a peri-urban area of South Africa | E-poster | Population-specific interventions for HIV prevention |
| LBEPC25 | Mathematical modeling of improving formal PrEP provision to MSM who are PrEP-eligible in the Netherlands: continuing and extending the national PrEP program is necessary | E-poster | Modelling the HIV epidemic |
| LBEPC26 | Preferences for long-acting HIV pre-exposure prophylaxis (PrEP) formulations among East and Southern African women – evidence from a discrete choice experiment (DCE) | E-poster | HIV prevention research |
| LBEPC27 | Prevention effective PrEP use in pregnancy and postpartum: evaluation of alignment of oral PrEP use and sex behaviors in South Africa | E-poster | Population-specific interventions for HIV prevention |